影响肝细胞癌腹腔镜肝切除患者预后的相关因素研究
Study on Prognostic Factors of Patients with Hepatocellular Carcinoma Undergoing Laparoscopic Hepatectomy
DOI: 10.12677/ACM.2022.123273, PDF,   
作者: 王荥昌, 邹 浩, 朱呈瞻, 胡剑翀, 孙传东*:青岛大学附属医院肝胆胰外科,山东 青岛;吕亚青:青岛大学附属医院伤口造口护理门诊,山东 青岛
关键词: 肝细胞癌腹腔镜肝切除术预后微血管侵犯Hepatocellular Carcinoma Laparoscopic Hepatectomy Prognosis Microvascular Invasion
摘要: 目的:探讨与肝细胞癌腹腔镜肝切除患者预后相关的独立危险因素及其相关指标。方法:回顾性分析青岛大学附属医院2017年1月至2019年12月期间收治的行腹腔镜肝切除术的肝细胞癌患者的临床资料及病理资料。分析影响肝细胞癌腹腔镜肝切除患者预后的危险因素,然后根据其有无危险因素进行分组,比较两组的临床病理资料,分析与危险因素发生相关的临床指标。结果:Cox回归分析结果显示微血管侵犯(microvascular invasion, MVI)是影响肝细胞癌腹腔镜肝切除患者无复发生存率(relapse-free survival, RFS)和总生存率(overall survival, OS)的独立危险因素。MVI阴性组受者术后1、3年OS和RFS分别为98.4%、96.6%和87.3%、64.8%,明显高于MVI阳性组的96.5%、75.2%和63.2%、32.3% (均为P < 0.05)。130例患者中,MVI阴性组患者65例(50%),MVI阳性组患者65例(50%)。两组患者临床病理资料显示,肿瘤直径越大、分化程度越低、肝被膜侵犯及伴卫星灶比例越高、术前甲胎蛋白(AFP)及总胆红素水平越高,发生MVI的可能性越大(均为P < 0.05)。结论:MVI是影响肝细胞癌腹腔镜肝切除患者预后的独立危险因素,肿瘤直径、分化程度等指标可能与其发生相关。
Abstract: Objective: To explore the independent risk factors and relevant indexes related to the prognosis of patients with hepatocellular carcinoma undergoing laparoscopic hepatectomy. Methods: The clinical and pathological data of patients with hepatocellular carcinoma treated by laparoscopic hepatectomy in the Affiliated Hospital of Qingdao University from January 2017 to December 2019 were analyzed retrospectively. Analyze the independent risk factors affecting the prognosis of patients with hepatocellular carcinoma undergoing laparoscopic hepatectomy, and then group them according to whether they have independent risk factors. Compare the clinical and pathological materials of the two groups, and analyze the clinical indicators related to the occurrence of independent risk factors. Results: Cox regression analysis showed that MVI was an independent risk factor for RFS and OS in patients undergoing laparoscopic hepatectomy for hepatocellular carcinoma. The 1-year and 3-year overall survival (OS) and recurrence free survival (RFS) in MVI negative group were 98.4%, 96.6% and 87.3%, 64.8% respectively, which were significantly higher than 96.5%, 75.2% and 63.2%, 32.3% in MVI positive group (all P < 0.05). Among the 130 patients, there were 65 patients (50%) in the MVI negative group and 65 patients (50%) in the MVI positive group. The clinical pathological data of the two groups showed that the larger the tumor diameter, the lower the degree of differentiation, the higher the proportion of liver envelope invasion and satellite lesions, and the higher the preoperative level of alpha fetoprotein (AFP) and total bilirubin, the greater the possibility of MVI (all P < 0.05). Conclusion: MVI is an independent risk factor affecting the prognosis of patients undergoing laparoscopic hepatectomy for hepatocellular carcinoma. Tumor diameter, degree of differentiation and other indicators may be related to its occurrence.
文章引用:王荥昌, 邹浩, 吕亚青, 朱呈瞻, 胡剑翀, 孙传东. 影响肝细胞癌腹腔镜肝切除患者预后的相关因素研究 [J]. 临床医学进展, 2022, 12(3): 1893-1902. https://doi.org/10.12677/ACM.2022.123273

参考文献

[1] Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries: Global Cancer Statistics 2018. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
[2] 张浩洋, 曹毅, 徐玥, 等. 乙肝相关性肝癌患者根治性切除术预后影响因素Cox回归分析[J]. 中国公共卫生, 2017, 33(11): 110-113.
[3] 程书蕙, 陈波, 李晔雄. 原发性肝癌术后辅助治疗的研究进展[J]. 中华放射肿瘤学杂志, 2019, 28(3): 233-237.
[4] 梅俊. 腹腔镜肝切除与开腹肝切除治疗原发性肝细胞癌临床研究[J]. 肝胆外科杂志, 2018, 26(1): 23-26.
[5] Erstad, D.J. and Tanabe, K.K. (2019) Prognostic and Therapeutic Implications of Microvascular Invasion in Hepatocellular Carcinoma. Annals of Surgical Oncology, 26, 812-820. [Google Scholar] [CrossRef] [PubMed]
[6] Zhang, X., Li, J., Shen, F., et al. (2017) Significance of Presence of Microvascular Invasion in Specimens Obtained after Surgical Treatment of Hepatocellular Carcinoma. Journal of Gastroenterology & Hepatology, 33, 347-354. [Google Scholar] [CrossRef] [PubMed]
[7] Vogel, A. and Saborowski, A. (2020) Current Strategies for the Treatment of Intermediate and Advanced Hepatocellular Carcinoma. Cancer Treatment Reviews, 82, Article ID: 101946. [Google Scholar] [CrossRef] [PubMed]
[8] Sayiner, M., Golabi, P. and Younossi, Z.M. (2019) Disease Burden of Hepatocellular Carcinoma: A Global Perspective. Digestive Diseases and Sciences, 64, 910-917. [Google Scholar] [CrossRef] [PubMed]
[9] Bertuccio, P., Turati, F., Carioli, G., et al. (2017) Global Trends and Predictions in Hepatocellular Carcinoma Mortality. Journal of Hepatology, 67, 302-309. [Google Scholar] [CrossRef] [PubMed]
[10] Xu, X., Chen, J., Wei, Q., et al. (2019) Clinical Practice Guidelines on Liver Transplantation for Hepatocellular Carcinoma in China (2018 Edition). Hepatobiliary & Pancreatic Diseases International, 18, 307-312. [Google Scholar] [CrossRef] [PubMed]
[11] 邓天芝, 陈晓梅, 龙洪航. 腹腔镜肝癌切除术对原发性肝癌患者血清恶性生物学指标及术后康复的影响[J]. 成都医学院学报, 2019, 14(1): 88-92.
[12] 欧阳正晟, 唐朝晖, 吕丽娟, 等. 腹腔镜肝切除与开腹肝切除治疗原发性肝癌的临床比较[J]. 中国普通外科杂志, 2017, 26(1): 126-130.
[13] 周皓岚, 贾贵清, 付英, 等. 腹腔镜肝癌切除术对原发性肝癌患者血清生物学指标及术后康复的影响[J]. 检验医学与临床, 2019, 16(10): 15-18.
[14] 张成武. 腹腔镜肝切除术治疗原发性肝癌[J]. 浙江医学, 2019, 41(17): 1808-1811.
[15] Reich, H., Mcglynn, F., Decaprio, J., et al. (1991) Laparoscopic Excision of Benign Liver Lesions. Obstetrics and Gynecology, 78, 956-958.
[16] 胡泽明, 陈彪, 钟佳宁, 等. 原发性肝癌治疗方法的应用进展[J]. 山东医药, 2019, 59(9): 106-110.
[17] Tan, T.C., Han, H.S., She, W.H., et al. (2018) The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Hepatocellular Carcinoma Expert Meeting Held in Hong Kong. Hepatocellular Carcinoma, 7, 28-39. [Google Scholar] [CrossRef] [PubMed]
[18] 胡继科, 李雪梅, 张凡, 等. 肝癌术后复发危险因素影响研究进展[J]. 中华肝胆外科杂志, 2018, 24(9): 644-648.
[19] 宋书红, 郭俊, 邹灿, 等. 肝癌手术切除术后复发相关因素分析[J]. 实用肝脏病杂志, 2017, 20(2): 79-82.
[20] 蒋亚波, 郭卫星, 程树群. 肝细胞癌伴门静脉癌栓发生机制的研究进展[J]. 中国细胞生物学学报, 2017, 39(2): 244-249.
[21] Goh, P.K., et al. (2014) 336. Number of Nodules, Child-Pugh Status, Margin Positivity and Microvascular Invasion but Not Tumour Size Are Prognostic Factors of Survival after Liver Resection for Multifocal Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery, 18, 1477-1485. [Google Scholar] [CrossRef
[22] Yang, P., Si, A., Yang, J., et al. (2018) A Wide-Margin Liver Resection Improves Long-Term Outcomes for Patients with HBV-Related Hepatocellular Carcinoma with Microvascular Invasion. Surgery, 165, 721-730. [Google Scholar] [CrossRef] [PubMed]
[23] Pommergaard, H.-C., et al. (2018) Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry. HPB (Oxford), 20, 768-775.
[24] 胡月雷, 孙大伟, 骆飞翔, 等. 单发肝细胞癌发生微血管侵犯的影响因素及预后分析[J]. 临床肝胆病杂志, 2018, 34(9): 1911-1916.
[25] Sumie, S., Kuromatsu, R., Okuda, K., et al. (2008) Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors. Annals of Surgical Oncology, 15, 1375-1382. [Google Scholar] [CrossRef] [PubMed]
[26] Zhang, W., Liu, L., Wang, P., et al. (2018) Preoperative Computed Tomography and Serum α-Fetoprotein to Predict Microvascular Invasion in Hepatocellular Carcinoma. Medicine, 97, e11402. [Google Scholar] [CrossRef
[27] Renzulli, M., Brocchi, S., CuCcHetti, A., et al. (2015) Can Current Preoperative Imaging Be Used to Detect Microvascular Invasion of Hepatocellular Carcinoma? Radiology, 279, Article ID: 150998. [Google Scholar] [CrossRef] [PubMed]
[28] Segal, E., Sirlin, C.B., Ooi, C., et al. (2007) Decoding Global Gene Expression Programs in Hepatocellular Carcinoma by Noninvasive Imaging. Nature Biotechnology, 25, 675-680.
[29] Banerjee, S., et al. (2015) A Computed Tomography Radiogenomic Biomarker Predicts Microvascular Invasion and Clinical Outcomes in Hepatocellular Carcinoma. Hepatology, 62, 792-800. [Google Scholar] [CrossRef] [PubMed]
[30] Lee, S., Kim, S.H., Ji, E.L., et al. (2017) Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Microvascular Invasion in Patients with Single Hepatocellular Carcinoma. Journal of Hepatology, 67, 526-534. [Google Scholar] [CrossRef] [PubMed]
[31] 陈培培, 陆健, 张涛, 等. 钆塞酸二钠增强MRI对肝细胞癌微血管侵犯的预测价值[J]. 中华放射学杂志, 2019, 53(2): 103-108.
[32] Hyun, S.H., Eo, J.S., Song, B.I., et al. (2017) Preoperative Prediction of Microvascular Invasion of Hepatocellular Carcinoma Using 18F-FDG PET/CT: A Multicenter Retrospective Cohort Study. European Journal of Nuclear Medicine and Molecular Imaging, 45, 720-726. [Google Scholar] [CrossRef] [PubMed]
[33] Koizumi, S., Yamashita, S., Matsumura, S., et al. (2020) Significance of a Preoperative Tumor Marker Gradient for Predicting Microvascular Invasion in Cases of Hepatocellular Carcinoma. Molecular and Clinical Oncology, 12, 290-294. [Google Scholar] [CrossRef] [PubMed]
[34] Lei, Z., Li, J., Dong, W., et al. (2016) Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma within the Milan Criteria. JAMA Surgery, 151, 356-363. [Google Scholar] [CrossRef] [PubMed]
[35] Imura, S., Teraoku, H., Yoshikawa, M., et al. (2017) Potential Predictive Factors for Microvascular Invasion in Hepatocellular Carcinoma Classified within the Milan Criteria. International Journal of Clinical Oncology, 23, 1-6. [Google Scholar] [CrossRef] [PubMed]
[36] Poté, N., Cauchy, F., Albuquerque, M., et al. (2015) Performance of PIVKA-II for Early Hepatocellular Carcinoma Diagnosis and Prediction of Microvascular Invasion. Journal of Hepatology, 62, 848-854. [Google Scholar] [CrossRef] [PubMed]
[37] Chen, L., Zhang, Q., Chang, W., et al. (2012) Viral and Host Inflammation-Related Factors That Can Predict the Prognosis of Hepatocellular Carcinoma. European Journal of Cancer, 48, 1977-1987. [Google Scholar] [CrossRef] [PubMed]
[38] Ryu, S.H., et al. (2010) Metastatic Tumor Antigen 1 Is Closely Associated with Frequent Postoperative Recurrence and Poor Survival in Patients with Hepatocellular Carcinoma. Hepatology, 47, 929-936.
[39] Bui-Nguyen, T.M., Pakala, S.B., Sirigiri, R.D., et al. (2010) NF-κB Signaling Mediates the Induction of MTA1 by Hepatitis B Virus Transactivator Protein HBx. Oncogene, 29, 1179-1189. [Google Scholar] [CrossRef] [PubMed]
[40] Yang, P., Li, Q.-J., Feng, Y., et al. (2012) TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma. Cancer Cell, 22, 291-303. [Google Scholar] [CrossRef] [PubMed]
[41] 杜培源, 宋京海, 乔江春, 等. 肝细胞癌患者微血管侵犯影响因素分析[J]. 中华肝胆外科杂志, 2019, 25(1): 26-29.
[42] Pawlik, T., Delman, K., Vauthey, J., et al. (2010) Tumor Size Predicts Vascular Invasion and Histologic Grade: Implications for Selection of Surgical Treatment for Hepatocellular Carcinoma. Liver Transplantation, 11, 1086-1092. [Google Scholar] [CrossRef] [PubMed]
[43] 曹国良, 蔡庆, 李幼安, 等. 肝细胞癌微血管侵犯的危险因素分析及预后[J]. 中华消化外科杂志, 2017(16): 1048-1052.
[44] Yin, C.Q., Yuan, C.H., Zhen, Q., et al. (2016) Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers. Disease Markers, 2016, Article ID: 1427849. [Google Scholar] [CrossRef] [PubMed]